BIOMARIN PHARMACEUTICAL INC Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for November 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Option Exercise | M | 63.10 | 9,000 | 567,900 | 30,700 | |
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 94.35 | 600 | 56,611 | 49,135 | 49.7 K to 49.1 K (-1.21 %) |
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 93.81 | 799 | 74,957 | 49,735 | 50.5 K to 49.7 K (-1.58 %) |
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 92.21 | 2,400 | 221,297 | 50,534 | 52.9 K to 50.5 K (-4.53 %) |
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 91.62 | 5,201 | 476,494 | 52,934 | 58.1 K to 52.9 K (-8.95 %) |
Nov 16 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Buy | M | 63.10 | 9,000 | 567,900 | 58,135 | 49.1 K to 58.1 K (+18.32 %) |
Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 4,000 | |
Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 97.88 | 1,500 | 146,820 | 288,290 | 289.8 K to 288.3 K (-0.52 %) |
Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 289,790 | 288.3 K to 289.8 K (+0.52 %) |
Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 99,000 | |
Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.55 | 4,000 | 370,200 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 103,000 | |
Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 288,290 | 287.3 K to 288.3 K (+0.35 %) |